Table 2.

Comparison of Up-to-Date Status Between Study Groups, at Baseline and at Follow-up, According to Intent-to-Treat Analysis Among All Women

			Unadjusted Comparison		Adjusted Comparison*
Screening	PCM No. (%) Up-to-Date	AMOP No. (%) Up-to-Date	OR (95% CI)	P Value	OR (95% CI)	P Value
Breast	(n=663)	(n=653)
Baseline	219 (33)	217 (33)	0.99 (0.78–1.26)	.94	0.97 (0.75–1.27)	.85
Follow-up	343 (52)	326 (50)	1.08 (0.86–1.34)	.51	1.16 (0.86–1.57)	.33
Cervical	(n=663)	(n=653)
Baseline	344 (52)	333 (51)	1.04 (0.83–1.29)	.75	1.03 (0.83–1.29)	.76
Follow-up	423 (64)	403 (62)	1.09 (0.87–1.38)	.43	1.18 (0.82–1.70)	.38
Colorectal†	(n=317)	(n=309)
Baseline	56 (18)	48 (16)	1.17 (0.75–1.82)	.47	–	–
Follow-up	103 (32)	78 (25)	1.43 (0.99–2.05)	.05	1.69‡ (1.03–2.77)	.04

PCM = prevention care management; AMOP = Affinity Mammography Outreach Program (the comparison group); OR = odds ratio; CI = confidence interval.

* Baseline breast and cervical comparisons are adjusted for age (40 to 49 years, 50 years and older); there is no adjusted colorectal baseline comparison because this analysis included only women aged 50 years and older. Follow-up comparisons are adjusted for age (breast and cervical) and for baseline screening status (all 3 screenings).

† Smaller n values for colorectal screening reflect the subset of the study population who were eligible for colorectal cancer screening (ie, aged 50 years and older).

‡P≤.05.